Inhibition of Bcl-2 and Bcl-xL overcomes the resistance to the third-generation EGFR tyrosine kinase inhibitor osimertinib in non-small cell lung cancer
Yingjie Lu(Huadong Hospital), Zhenghong Zhu(Fudan University)
Cited by 29
Related Papers
No related papers found
Powered by citation graph analysis